Charles Schwab’s OrthoPediatrics KIDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.74M | Buy |
143,127
+4,030
| +3% | +$70.1K | ﹤0.01% | 2680 |
|
|
2026
Q1 | $2.21M | Buy |
139,097
+3,622
| +3% | +$63.3K | ﹤0.01% | 2692 |
|
|
2025
Q4 | $2.41M | Buy |
135,475
+4,360
| +3% | +$76.3K | ﹤0.01% | 2706 |
|
|
2025
Q3 | $2.43M | Sell |
131,115
-7,369
| -5% | -$152K | ﹤0.01% | 2703 |
|
|
2025
Q2 | $2.97M | Buy |
138,484
+4,204
| +3% | +$90.9K | ﹤0.01% | 2550 |
|
|
2025
Q1 | $3.31M | Sell |
134,280
-1,954
| -1% | -$48.3K | ﹤0.01% | 2445 |
|
|
2024
Q4 | $3.16M | Buy |
136,234
+3,800
| +3% | +$95K | ﹤0.01% | 2536 |
|
|
2024
Q3 | $3.59M | Buy |
132,434
+2,661
| +2% | +$80.6K | ﹤0.01% | 2525 |
|
|
2024
Q2 | $3.73M | Buy |
129,773
+5,345
| +4% | +$164K | ﹤0.01% | 2486 |
|
|
2024
Q1 | $3.63M | Buy |
124,428
+1,275
| +1% | +$35.7K | ﹤0.01% | 2402 |
|
|
2023
Q4 | $4M | Buy |
123,153
+1,422
| +1% | +$41.2K | ﹤0.01% | 2398 |
|
|
2023
Q3 | $3.9M | Buy |
121,731
+549
| +0.5% | +$21.1K | ﹤0.01% | 2362 |
|
|
2023
Q2 | $5.31M | Buy |
121,182
+3,600
| +3% | +$166K | ﹤0.01% | 2220 |
|
|
2023
Q1 | $5.21M | Buy |
117,582
+1,196
| +1% | +$52.9K | ﹤0.01% | 2186 |
|
|
2022
Q4 | $4.62M | Buy |
116,386
+11,476
| +11% | +$478K | ﹤0.01% | 2251 |
|
|
2022
Q3 | $4.84M | Buy |
104,910
+2,329
| +2% | +$114K | ﹤0.01% | 2230 |
|
|
2022
Q2 | $4.43M | Buy |
102,581
+804
| +0.8% | +$36.8K | ﹤0.01% | 2241 |
|
|
2022
Q1 | $5.5M | Buy |
101,777
+3,655
| +4% | +$187K | ﹤0.01% | 2230 |
|
|
2021
Q4 | $5.87M | Buy |
98,122
+1,130
| +1% | +$70.3K | ﹤0.01% | 2270 |
|
|
2021
Q3 | $6.35M | Buy |
96,992
+3,137
| +3% | +$204K | ﹤0.01% | 2259 |
|
|
2021
Q2 | $5.93M | Buy |
93,855
+3,216
| +4% | +$185K | ﹤0.01% | 2264 |
|
|
2021
Q1 | $4.42M | Sell |
90,639
-15,886
| -15% | -$762K | ﹤0.01% | 2360 |
|
|
2020
Q4 | $4.39M | Sell |
106,525
-306
| -0.3% | -$14K | ﹤0.01% | 2285 |
|
|
2020
Q3 | $4.91M | Buy |
106,831
+60,082
| +129% | +$2.79M | ﹤0.01% | 2066 |
|
|
2020
Q2 | $2.05M | Buy |
46,749
+7,352
| +19% | +$331K | ﹤0.01% | 2418 |
|
|
2020
Q1 | $1.56M | Buy |
39,397
+14,445
| +58% | +$647K | ﹤0.01% | 2362 |
|
|
2019
Q4 | $1.17M | Sell |
24,952
-581
| -2% | -$22.5K | ﹤0.01% | 2548 |
|
|
2019
Q3 | $901K | Buy |
25,533
+5,275
| +26% | +$183K | ﹤0.01% | 2606 |
|
|
2019
Q2 | $791K | Buy |
20,258
+2,476
| +14% | +$99.8K | ﹤0.01% | 2654 |
|
|
2019
Q1 | $787K | Buy |
17,782
+1,822
| +11% | +$69.3K | ﹤0.01% | 2623 |
|
|
2018
Q4 | $557K | Buy |
15,960
+1,060
| +7% | +$33.6K | ﹤0.01% | 2725 |
|
|
2018
Q3 | $546K | Buy |
14,900
+2,000
| +16% | +$61.3K | ﹤0.01% | 2805 |
|
|
2018
Q2 | $344K | Buy |
+12,900
| New | +$275K | ﹤0.01% | 2918 |
|
Other funds holding KIDS
B
GIM
SCM
WA
Charles Schwab's KIDS Position: Q2 2026 in Review
Charles Schwab increased its OrthoPediatrics (KIDS) stake by 2.9% in Q2 2026, buying an estimated $70.1K and bringing the position to 143,127 shares worth $2.74M. The position accounts for ﹤0.01% of the portfolio, ranked #2680.
Charles Schwab first reported a position in KIDS in Q2 2018 and has held it in 33 quarters since. The position peaked at $6.35M in Q3 2021. 120 funds tracked by Wall St. Rank hold KIDS as of Q2 2026.
- Charles Schwab held 143,127 shares of OrthoPediatrics worth $2.74M as of Q2 2026.
- Charles Schwab bought 4,030 OrthoPediatrics shares in Q2 2026, an estimated $70.1K.
- OrthoPediatrics made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2680 holding.
- Charles Schwab first reported a position in OrthoPediatrics in Q2 2018 and has held it in 33 quarters since.
- Charles Schwab's OrthoPediatrics position peaked at $6.35M in Q3 2021.
- 120 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.